Search for "interconversion" in Full Text gives 146 result(s) in Beilstein Journal of Organic Chemistry.
Beilstein J. Org. Chem. 2017, 13, 111–119, doi:10.3762/bjoc.13.14
Graphical Abstract
Scheme 1: The reaction of (R)-(−)-carvone (1) with semicarbazide to form the corresponding semicarbazone 2.
Figure 1: CAD model of SL reactor design RD1 (left), RD1 with attached sprung clip (centre), commercially ava...
Figure 2: Energy versus wavelength spectra comparing the amount of stray light being picked up by the detecto...
Figure 3: Reactor set-up for carvone optimisation using RD1 as an inline spectroscopic flow cell. Reagents we...
Figure 4: RD1 held in place within the DAD compartment of an Agilent 1100 HPLC.
Figure 5: Optimisation plot for the SIMPLEX optimisation of semicarbazone 2. Optimum reaction conditions with...
Figure 6: SLM reactor RD2 (left), CAD model of RD2 (right). External dimensions of RD2 are 100 (length) × 20 ...
Figure 7: RD2 held in place within the thermostatted Agilent 1100 series column department.
Figure 8: Optimisation plot for the SIMPLEX optimisation of semicarbazone 1. Optimum reaction conditions were...
Scheme 2: The reaction of pentafluoropyridine (3) with 2-(methylamino)phenol (4) to form the corresponding fu...
Figure 9: Optimisation plot for the SIMPLEX optimisation of the fused polycyclic heterocycle 5. Two optimal d...
Figure 10: SLM reactor design RD3 (left), CAD model of RD3 (right). External dimensions of RD3 are 89 (length)...
Figure 11: Optimisation plot for the SIMPLEX optimisation of semicarbazone 2. Optimum reaction conditions were...
Beilstein J. Org. Chem. 2016, 12, 2478–2489, doi:10.3762/bjoc.12.242
Graphical Abstract
Scheme 1: Preparation of the nitro derivatives 4a and 5a and the fluorine-containing compounds 4b and 5b. Rea...
Figure 1: 1H NMR spectra of compound 3a measured in five different solvents: (A) CDCl3, (B) DMSO-d6, (C) acet...
Figure 2: HSQC and H,H-COSY (small spectrum) of compound 3a measured in CDCl3 at 25 °C. The independent coupl...
Figure 3: Illustration of the general partial double bond character of an amide bond and the limited isomeriz...
Figure 4: Temperature-dependent 1H NMR spectra of 3a measured in DMSO-d6 (aliphatic region of the piperazine ...
Figure 5: Molecular structure of compound 3a (ORTEP plot with 50% probability level).
Figure 6: Molecular structure of compound 4b (ORTEP plot with 50% probability level).
Figure 7: Superimposition fit of the two conformers, which exist in the ratio of 1:1 in the solid state struc...
Scheme 2: Peptide labeling using the Huisgen-click reaction and building block 4b. Reagents and conditions: a...
Scheme 3: The traceless Staudinger ligation to yield compound 9. Reagents and conditions: a) acetonitrile/wat...
Scheme 4: Preparation of the radiolabeling building blocks [18F]4b and [18F]5b. Reagents and conditions: a) K[...
Figure 8: Radio-TLC (eluent: ethanol) of [18F]5b (Rf = 0.50; reaction mixture).
Figure 9: (Radio)HPLC of 5a (tR = 7.7 min, UV trace, red), 5b (tR = 6.7 min, UV trace: blue) and [18F]5b (tR ...
Beilstein J. Org. Chem. 2016, 12, 1839–1850, doi:10.3762/bjoc.12.173
Graphical Abstract
Figure 1: Structures of sesquiterpenes obtained by incubation of FPP with bacterial sesquiterpene cyclases.
Figure 2: Contiguous spin systems observed by 1H,1H-COSY (bold), key HMBC and NOE correlations for a) α-amorp...
Figure 3: Contiguous spin systems observed by 1H,1H-COSY (bold), key HMBC and NOE correlations for a) 7-epi-α...
Scheme 1: Biosynthetic pathway from FPP to 7-epi-α-eudesmol (4).
Figure 4: Incubation experiments with (6-13C)FPP and the 7-epi-α-eudesmol synthase in deuterium oxide. a) 13C...
Figure 5: Incubation experiments with (13-13C)FPP. 13C NMR spectra of a) unlabelled 1 and (13-13C)-1, b) unla...
Beilstein J. Org. Chem. 2016, 12, 1647–1748, doi:10.3762/bjoc.12.162
Graphical Abstract
Figure 1: The named transformations considered in this review.
Scheme 1: The Baeyer–Villiger oxidation.
Scheme 2: The general mechanism of the peracid-promoted Baeyer–Villiger oxidation.
Scheme 3: General mechanism of the Lewis acid-catalyzed Baeyer–Villiger rearrangement.
Scheme 4: The theoretically studied mechanism of the BV oxidation reaction promoted by H2O2 and the Lewis aci...
Scheme 5: Proton movements in the transition states of the Baeyer–Villiger oxidation.
Scheme 6: The dependence of the course of the Baeyer–Villiger oxidation on the type of O–O-bond cleavage in t...
Scheme 7: The acid-catalyzed Baeyer–Villiger oxidation of cyclic epoxy ketones 22.
Scheme 8: Oxidation of isophorone oxide 29.
Scheme 9: Synthesis of acyl phosphate 32 from acyl phosphonate 31.
Scheme 10: Synthesis of aflatoxin B2 (36).
Scheme 11: The Baeyer–Villiger rearrangement of ketones 37 to lactones 38.
Scheme 12: Synthesis of 3,4-dimethoxybenzoic acid (40) via Baeyer–Villiger oxidation.
Scheme 13: Oxone transforms α,β-unsaturated ketones 43 into vinyl acetates 44.
Scheme 14: The Baeyer–Villiger oxidation of ketones 45 using diaryl diselenide and hydrogen peroxide.
Scheme 15: Baeyer–Villiger oxidation of (E)-2-methylenecyclobutanones.
Scheme 16: Oxidation of β-ionone (56) by H2O2/(BnSe)2 with formation of (E)-2-(2,6,6-trimethylcyclohex-1-en-1-...
Scheme 17: The mechanism of oxidation of ketones 58a–f by hydrogen peroxide in the presence of arsonated polys...
Scheme 18: Oxidation of ketone (58b) by H2O2 to 6-methylcaprolactone (59b) catalyzed by Pt complex 66·BF4.
Scheme 19: Oxidation of ketones 67 with H2O2 in the presence of [(dppb}Pt(µ-OH)]22+.
Scheme 20: The mechanism of oxidation of ketones 67 in the presence of [(dppb}Pt(µ-OH)]22+ and H2O2.
Scheme 21: Oxidation of benzaldehydes 69 in the presence of the H2O2/MeReO3 system.
Scheme 22: Oxidation of acetophenones 72 in the presence of the H2O2/MeReO3 system.
Scheme 23: Baeyer–Villiger oxidation of 2-adamantanone (45c) in the presence of Sn-containing mesoporous silic...
Scheme 24: Aerobic Baeyer–Villiger oxidation of ketones 76 using metal-free carbon.
Scheme 25: A regioselective Baeyer-Villiger oxidation of functionalized cyclohexenones 78 into a dihydrooxepin...
Scheme 26: The oxidation of aldehydes and ketones 80 by H2O2 catalyzed by Co4HP2Mo15V3O62.
Scheme 27: The cleavage of ketones 82 with hydrogen peroxide in alkaline solution.
Scheme 28: Oxidation of ketones 85 to esters 86 with H2O2–urea in the presence of KHCO3.
Scheme 29: Mechanism of the asymmetric oxidation of cyclopentane-1,2-dione 87a with the Ti(OiPr)4/(+)DET/t-BuO...
Scheme 30: The oxidation of cis-4-tert-butyl-2-fluorocyclohexanone (93) with m-chloroperbenzoic acid.
Scheme 31: The mechanism of the asymmetric oxidation of 3-substituted cyclobutanone 96a in the presence of chi...
Scheme 32: Enantioselective Baeyer–Villiger oxidation of cyclic ketones 98.
Scheme 33: Regio- and enantioselective Baeyer–Villiger oxidation of cyclic ketones 101.
Scheme 34: The proposed mechanism of the Baeyer–Villiger oxidation of acetal 105f.
Scheme 35: Synthesis of hydroxy-10H-acridin-9-one 117 from tetramethoxyanthracene 114.
Scheme 36: The Baeyer–Villiger oxidation of the fully substituted pyrrole 120.
Scheme 37: The Criegee rearrangement.
Scheme 38: The mechanism of the Criegee reaction of a peracid with a tertiary alcohol 122.
Scheme 39: Criegee rearrangement of decaline ethylperoxoate 127 into ketal 128.
Scheme 40: The ionic cleavage of 2-methoxy-2-propyl perester 129.
Scheme 41: The Criegee rearrangement of α-methoxy hydroperoxide 136.
Scheme 42: Synthesis of enol esters and acetals via the Criegee rearrangement.
Scheme 43: Proposed mechanism of the transformation of 1-hydroperoxy-2-oxabicycloalkanones 147a–d.
Scheme 44: Transformation of 3-hydroxy-1,2-dioxolanes 151 into diketone derivatives 152.
Scheme 45: Criegee rearrangement of peroxide 153 with the mono-, di-, and tri-O-insertion.
Scheme 46: The sequential Criegee rearrangements of adamantanes 157a,b.
Scheme 47: Synthesis of diaryl carbonates 160a–d from triarylmethanols 159a–d through successive oxygen insert...
Scheme 48: The synthesis of sesquiterpenes 162 from ketone 161 with a Criegee rearrangement as one key step.
Scheme 49: Synthesis of trans-hydrindan derivatives 164, 165.
Scheme 50: The Hock rearrangement.
Scheme 51: The general scheme of the cumene process.
Scheme 52: The Hock rearrangement of aliphatic hydroperoxides.
Scheme 53: The mechanism of solvolysis of brosylates 174a–c and spiro cyclopropyl carbinols 175a–c in THF/H2O2....
Scheme 54: The fragmentation mechanism of hydroperoxy acetals 178 to esters 179.
Scheme 55: The acid-catalyzed rearrangement of phenylcyclopentyl hydroperoxide 181.
Scheme 56: The peroxidation of tertiary alcohols in the presence of a catalytic amount of acid.
Scheme 57: The acid-catalyzed reaction of bicyclic secondary alcohols 192 with hydrogen peroxide.
Scheme 58: The photooxidation of 5,6-disubstituted 3,4-dihydro-2H-pyrans 196.
Scheme 59: The oxidation of tertiary alcohols 200a–g, 203a,b, and 206.
Scheme 60: Transformation of functional peroxide 209 leading to 2,3-disubstitued furans 210 in one step.
Scheme 61: The synthesis of carbazoles 213 via peroxide rearrangement.
Scheme 62: The construction of C–N bonds using the Hock rearrangement.
Scheme 63: The synthesis of moiety 218 from 217 which is a structural motif in the antitumor–antibiotic of CC-...
Scheme 64: The in vivo oxidation steps of cholesterol (219) by singlet oxygen.
Scheme 65: The proposed mechanism of the rearrangement of cholesterol-5α-OOH 220.
Scheme 66: Photochemical route to artemisinin via Hock rearrangement of 223.
Scheme 67: The Kornblum–DeLaMare rearrangement.
Scheme 68: Kornblum–DeLaMare transformation of 1-phenylethyl tert-butyl peroxide (225).
Scheme 69: The synthesis 4-hydroxyenones 230 from peroxide 229.
Scheme 70: The Kornblum–DeLaMare rearrangement of peroxide 232.
Scheme 71: The reduction of peroxide 234.
Scheme 72: The Kornblum–DeLaMare rearrangement of endoperoxide 236.
Scheme 73: The rearrangement of peroxide 238 under Kornblum–DeLaMare conditions.
Scheme 74: The proposed mechanism of rearrangement of peroxide 238.
Scheme 75: The Kornblum–DeLaMare rearrangement of peroxides 242a,b.
Scheme 76: The base-catalyzed rearrangements of bicyclic endoperoxides having electron-withdrawing substituent...
Scheme 77: The base-catalyzed rearrangements of bicyclic endoperoxides 249a,b having electron-donating substit...
Scheme 78: The base-catalyzed rearrangements of bridge-head substituted bicyclic endoperoxides 251a,b.
Scheme 79: The Kornblum–DeLaMare rearrangement of hydroperoxide 253.
Scheme 80: Synthesis of β-hydroxy hydroperoxide 254 from endoperoxide 253.
Scheme 81: The amine-catalyzed rearrangement of bicyclic endoperoxide 263.
Scheme 82: The base-catalyzed rearrangement of meso-endoperoxide 268 into 269.
Scheme 83: The photooxidation of 271 and subsequent Kornblum–DeLaMare reaction.
Scheme 84: The Kornblum–DeLaMare rearrangement as one step in the oxidation reaction of enamines.
Scheme 85: The Kornblum–DeLaMare rearrangement of 3,5-dihydro-1,2-dioxenes 284, 1,2-dioxanes 286, and tert-but...
Scheme 86: The Kornblum–DeLaMare rearrangement of epoxy dioxanes 290a–d.
Scheme 87: Rearrangement of prostaglandin H2 292.
Scheme 88: The synthesis of epicoccin G (297).
Scheme 89: The Kornblum–DeLaMare rearrangement used in the synthesis of phomactin A.
Scheme 90: The Kornblum–DeLaMare rearrangement in the synthesis of 3H-quinazolin-4-one 303.
Scheme 91: The Kornblum–DeLaMare rearrangement in the synthesis of dolabriferol (308).
Scheme 92: Sequential transformation of 3-substituted 2-pyridones 309 into 3-hydroxypyridine-2,6-diones 311 in...
Scheme 93: The Kornblum–DeLaMare rearrangement of peroxide 312 into hydroxy enone 313.
Scheme 94: The Kornblum–DeLaMare rearrangement in the synthesis of polyfunctionalized carbonyl compounds 317.
Scheme 95: The Kornblum–DeLaMare rearrangement in the synthesis of (Z)-β-perfluoroalkylenaminones 320.
Scheme 96: The Kornblum–DeLaMare rearrangement in the synthesis of γ-ketoester 322.
Scheme 97: The Kornblum–DeLaMare rearrangement in the synthesis of diterpenoids 326 and 328.
Scheme 98: The synthesis of natural products hainanolidol (331) and harringtonolide (332) from peroxide 329.
Scheme 99: The synthesis of trans-fused butyrolactones 339 and 340.
Scheme 100: The synthesis of leucosceptroid C (343) and leucosceptroid P (344) via the Kornblum–DeLaMare rearra...
Scheme 101: The Dakin oxidation of arylaldehydes or acetophenones.
Scheme 102: The mechanism of the Dakin oxidation.
Scheme 103: A solvent-free Dakin reaction of aromatic aldehydes 356.
Scheme 104: The organocatalytic Dakin oxidation of electron-rich arylaldehydes 358.
Scheme 105: The Dakin oxidation of electron-rich arylaldehydes 361.
Scheme 106: The Dakin oxidation of arylaldehydes 358 in water extract of banana (WEB).
Scheme 107: A one-pot approach towards indolo[2,1-b]quinazolines 364 from indole-3-carbaldehydes 363 through th...
Scheme 108: The synthesis of phenols 367a–c from benzaldehydes 366a-c via acid-catalyzed Dakin oxidation.
Scheme 109: Possible transformation paths of the highly polarized boric acid coordinated H2O2–aldehyde adduct 3...
Scheme 110: The Elbs oxidation of phenols 375 to hydroquinones.
Scheme 111: The mechanism of the Elbs persulfate oxidation of phenols 375 affording p-hydroquinones 376.
Scheme 112: Oxidation of 2-pyridones 380 under Elbs persulfate oxidation conditions.
Scheme 113: Synthesis of 3-hydroxy-4-pyridone (384) via an Elbs oxidation of 4-pyridone (382).
Scheme 114: The Schenck rearrangement.
Scheme 115: The Smith rearrangement.
Scheme 116: Three main pathways of the Schenck rearrangement.
Scheme 117: The isomerization of hydroperoxides 388 and 389.
Scheme 118: Trapping of dioxacyclopentyl radical 392 by oxygen.
Scheme 119: The hypothetical mechanism of the Schenck rearrangement of peroxide 394.
Scheme 120: The autoxidation of oleic acid (397) with the use of labeled isotope 18O2.
Scheme 121: The rearrangement of 18O-labeled hydroperoxide 400 under an atmosphere of 16O2.
Scheme 122: The rearrangement of the oleate-derived allylic hydroperoxides (S)-421 and (R)-425.
Scheme 123: Mechanisms of Schenck and Smith rearrangements.
Scheme 124: The rearrangement and cyclization of 433.
Scheme 125: The Wieland rearrangement.
Scheme 126: The rearrangement of bis(triphenylsilyl) 439 or bis(triphenylgermyl) 441 peroxides.
Scheme 127: The oxidative transformation of cyclic ketones.
Scheme 128: The hydroxylation of cyclohexene (447) in the presence of tungstic acid.
Scheme 129: The oxidation of cyclohexene (447) under the action of hydrogen peroxide.
Scheme 130: The reaction of butenylacetylacetone 455 with hydrogen peroxide.
Scheme 131: The oxidation of bridged 1,2,4,5-tetraoxanes.
Scheme 132: The proposed mechanism for the oxidation of bridged 1,2,4,5-tetraoxanes.
Scheme 133: The rearrangement of ozonides.
Scheme 134: The acid-catalyzed oxidative rearrangement of malondialdehydes 462 under the action of H2O2.
Scheme 135: Pathways of the Lewis acid-catalyzed cleavage of dialkyl peroxides 465 and ozonides 466.
Scheme 136: The mechanism of the transformation of (tert-butyldioxy)cyclohexanedienones 472.
Scheme 137: The synthesis of Vitamin K3 from 472a.
Scheme 138: Proposed mechanism for the transformation of 478d into silylated endoperoxide 479d.
Scheme 139: The rearrangement of hydroperoxide 485 to form diketone 486.
Scheme 140: The base-catalyzed rearrangement of cyclic peroxides 488a–g.
Scheme 141: Synthesis of chiral epoxides and aldols from peroxy hemiketals 491.
Scheme 142: The multistep transformation of (R)-carvone (494) to endoperoxides 496a–e.
Scheme 143: The decomposition of anthracene endoperoxide 499.
Scheme 144: Synthesis of esters 503 from aldehydes 501 via rearrangement of peroxides 502.
Scheme 145: Two possible paths for the base-promoted decomposition of α-azidoperoxides 502.
Scheme 146: The Story decomposition of cyclic diperoxide 506a.
Scheme 147: The Story decomposition of cyclic triperoxide 506b.
Scheme 148: The thermal rearrangement of endoperoxides A into diepoxides B.
Scheme 149: The transformation of peroxide 510 in the synthesis of stemolide (511).
Scheme 150: The possible mechanism of the rearrangement of endoperoxide 261g.
Scheme 151: The photooxidation of indene 517.
Scheme 152: The isomerization of ascaridole (523).
Scheme 153: The isomerization of peroxide 525.
Scheme 154: The thermal transformation of endoperoxide 355.
Scheme 155: The photooxidation of cyclopentadiene (529) at a temperature higher than 0 °C.
Scheme 156: The thermal rearrangement of endoperoxides 538a,b.
Scheme 157: The transformation of peroxides 541.
Scheme 158: The thermal rearrangements of strained cyclic peroxides.
Scheme 159: The thermal rearrangement of diacyl peroxide 551 in the synthesis of C4-epi-lomaiviticin B core 553....
Scheme 160: The 1O2 oxidation of tryptophan (554) and rearrangement of dioxetane intermediate 555.
Scheme 161: The Fe(II)-promoted cleavage of aryl-substituted bicyclic peroxides.
Scheme 162: The proposed mechanism of the Fe(II)-promoted rearrangement of 557a–c.
Scheme 163: The reaction of dioxolane 563 with Fe(II) sulfate.
Scheme 164: Fe(II)-promoted rearrangement of 1,2-dioxane 565.
Scheme 165: Fe(II) cysteinate-promoted rearrangement of 1,2-dioxolane 568.
Scheme 166: The transformation of 1,2-dioxanes 572a–c under the action of FeCl2.
Scheme 167: Fe(II) cysteinate-promoted transformation of tetraoxane 574.
Scheme 168: The CoTPP-catalyzed transformation of bicyclic endoperoxides 600a–d.
Scheme 169: The CoTPP-catalyzed transformation of epoxy-1,2-dioxanes.
Scheme 170: The Ru(II)-catalyzed reactions of 1,4-endoperoxide 261g.
Scheme 171: The Ru(II)-catalyzed transformation as a key step in the synthesis of elyiapyrone A (610) from 1,4-...
Scheme 172: Peroxides with antimalarial activity.
Scheme 173: The interaction of iron ions with artemisinin (616).
Scheme 174: The interaction of FeCl2 with 1,2-dioxanes 623, 624.
Scheme 175: The mechanism of reaction 623 and 624 with Fe(II)Cl2.
Scheme 176: The reaction of bicyclic natural endoperoxides G3-factors 631–633 with FeSO4.
Scheme 177: The transformation of terpene cardamom peroxide 639.
Scheme 178: The different ways of the cleavage of tetraoxane 643.
Scheme 179: The LC–MS analysis of interaction of tetraoxane 646 with iron(II)heme 647.
Scheme 180: The rearrangement of 3,6-epidioxy-1,10-bisaboladiene (EDBD, 649).
Scheme 181: Easily oxidized substrates.
Scheme 182: Biopathway of synthesis of prostaglandins.
Scheme 183: The reduction and rearrangements of isoprostanes.
Scheme 184: The partial mechanism for linoleate 658 oxidation.
Scheme 185: The transformation of lipid hydroperoxide.
Scheme 186: The acid-catalyzed cleavage of the product from free-radical oxidation of cholesterol (667).
Scheme 187: Two pathways of catechols oxidation.
Scheme 188: Criegee-like or Hock-like rearrangement of the intermediate hydroperoxide 675 in dioxygenase enzyme...
Scheme 189: Carotinoides 679 cleavage by carotenoid cleavage dioxygenases.
Beilstein J. Org. Chem. 2016, 12, 1616–1623, doi:10.3762/bjoc.12.158
Graphical Abstract
Figure 1: Intramolecular aryl–vinyl π-stacking interaction of a levoglucosenone derivative.
Scheme 1: Synthesis of acrylates 6a,b.
Figure 2: Vinyl region of the 1H NMR spectra of 6a–d in CDCl3 at 300 K.
Figure 3: Vinylic region of the low temperatures 1H NMR spectra of 6a in CDCl3.
Figure 4: M06-2X/6-31+G(d) Gibbs free energy profiles (in kcal/mol) computed for the conformational equilibri...
Scheme 2: Complexes between methyl acrylate (7) and representative anisole derivatives.
Figure 5: Comparison of the M06-2X/6-31+G(d) energy profiles (in kcal/mol) computed for 6d and 6b (in grey).
Figure 6: X-ray thermal ellipsoid plot of 6a (50% probability level) showing the labeling scheme (hydrogen an...
Beilstein J. Org. Chem. 2016, 12, 1512–1550, doi:10.3762/bjoc.12.148
Graphical Abstract
Scheme 1: Schematic description of the cyclisation reaction catalysed by TE domains. In most cases, the nucle...
Scheme 2: Mechanisms for the formation of oxygen heterocycles. The degree of substitution can differ from tha...
Scheme 3: Pyran-ring formation in pederin (24) biosynthesis. Incubation of recombinant PedPS7 with substrate ...
Scheme 4: The domain AmbDH3 from ambruticin biosynthesis catalyses the dehydration of 25 and subsequent cycli...
Scheme 5: SalBIII catalyses dehydration of 29 and subsequent cyclisation to tetrahydropyran 30 [18].
Figure 1: All pyranonaphtoquinones contain either the naphtha[2,3-c]pyran-5,10-dione (32) or the regioisomeri...
Scheme 6: Pyran-ring formation in actinorhodin (34) biosynthesis. DNPA: 4-dihydro-9-hydroxy-1-methyl-10-oxo-3H...
Scheme 7: Pyran formation in granaticin (36) biosynthesis. DNPA: 4-dihydro-9-hydroxy-1-methyl-10-oxo-3H-napht...
Scheme 8: Pyran formation in alnumycin (37) biosynthesis. Adapted from [21].
Scheme 9: Biosynthesis of pseudomonic acid A (61). The pyran ring is initially formed in 57 after dehydrogena...
Scheme 10: Epoxidation–cyclisation leads to the formation of the tetrahydropyran ring in the western part of t...
Scheme 11: a) Nonactin (70) is formed from heterodimers of (−)(+)-dimeric nonactic acid and (+)(−)-dimeric non...
Figure 2: Pamamycins (73) are macrodiolide antibiotics containing three tetrahydrofuran moieties, which are a...
Scheme 12: A PS domain homolog in oocydin A (76) biosynthesis is proposed to catalyse furan formation via an o...
Scheme 13: Mechanism of oxidation–furan cyclisation by AurH, which converts (+)-deoxyaureothin (77) into (+)-a...
Scheme 14: Leupyrrin A2 (80) and the proposed biosynthesis of its furylidene moiety [69,70].
Scheme 15: Asperfuranone (93) biosynthesis, adapted from [75].
Figure 3: The four major aflatoxins produced by Aspergilli are the types B1, B2, G1 and G2 (94–97). In the di...
Scheme 16: Overview on aflatoxin B1 (94) biosynthesis. HOMST = 11-hydroxy-O-methylsterigmatocystin [78,79,82-106].
Scheme 17: A zipper mechanism leads to the formation of oxygen heterocycles in monensin biosynthesis [109-111].
Scheme 18: Formation of the 2,6-dioxabicyclo[3.2.1]octane (DBO) ring system in aurovertin B (118) biosynthesis ...
Figure 4: Structures of the epoxide-containing polyketides epothilone A (119) and oleandomycin (120) [123-125].
Scheme 19: Structures of phoslactomycin B (121) (a) and jerangolid A (122) (b). The heterocycle-forming steps ...
Scheme 20: a) Structures of rhizoxin (130) and cycloheximide (131). Model for the formation of δ-lactones (b) ...
Scheme 21: EncM catalyses a dual oxidation sequence and following processing of the highly reactive intermedia...
Figure 5: Mesomeric structures of tetronates [138,139].
Figure 6: Structures of tetronates for which gene clusters have been sequenced. The tetronate moiety is shown...
Scheme 22: Conserved steps for formation and processing in several 3-acyl-tetronate biosynthetic pathways were...
Scheme 23: In versipelostatin A (153) biosynthesis, VstJ is a candidate enzyme for catalysing the [4 + 2] cycl...
Scheme 24: a) Structures of some thiotetronate antibiotics. b) Biosynthesis of thiolactomycin (165) as propose...
Scheme 25: Aureusidine synthase (AS) catalyses phenolic oxidation and conjugate addition of chalcones leading ...
Scheme 26: a) Oxidative cyclisation is a key step in the biosynthesis of spirobenzofuranes 189, 192 and 193. b...
Scheme 27: A bicyclisation mechanism forms a β-lactone and a pyrrolidinone and removes the precursor from the ...
Scheme 28: Spontaneous cyclisation leads to off-loading of ebelactone A (201) from the PKS machinery [163].
Scheme 29: Mechanisms for the formation of nitrogen heterocycles.
Scheme 30: Biosynthesis of highly substituted α-pyridinones. a) Feeding experiments confirmed the polyketide o...
Scheme 31: Acridone synthase (ACS) catalyses the formation of 1,3-dihydroxy-N-methylacridone (224) by condensa...
Scheme 32: A Dieckmann condensation leads to the formation of a 3-acyl-4-hydroxypyridin-2-one 227 and removes ...
Scheme 33: a) Biosynthesis of the pyridinone tenellin (234). b) A radical mechanism was proposed for the ring-...
Scheme 34: a) Oxazole-containing PKS–NRPS-derived natural products oxazolomycin (244) and conglobatin (245). b...
Scheme 35: Structure of tetramic acids 251 (a) and major tautomers of 3-acyltetramic acids 252a–d (b). Adapted...
Scheme 36: Equisetin biosynthesis. R*: terminal reductive domain. Adapted from [202].
Scheme 37: a) Polyketides for which a similar biosynthetic logic was suggested. b) Pseurotin A (256) biosynthe...
Figure 7: Representative examples of PTMs with varying ring sizes and oxidation patterns [205,206].
Scheme 38: Ikarugamycin biosynthesis. Adapted from [209-211].
Scheme 39: Tetramate formation in pyrroindomycin aglycone (279) biosynthesis [213-215].
Scheme 40: Dieckmann cyclases catalyse tetramate or 2-pyridone formation in the biosynthesis of, for example, ...
Beilstein J. Org. Chem. 2016, 12, 1453–1458, doi:10.3762/bjoc.12.141
Graphical Abstract
Figure 1: Synthetic overview of “NU-BIPHEP(O)s”. A) Rhodium catalyzed double [2 + 2 + 2] cycloaddition. B) Ac...
Figure 2: Investigation of 3,5-dichlorobenzoyl modified tetrahydrobiisoindole “NU-BIPHEP(O)” 3. A) Three sign...
Figure 3: Investigation of “NU-BIPHEP(O)” 1b. A) Solid-state structure determined by X-ray crystallography. H...
Figure 4: Enantioselective DHPLC investigation of tetrahydrobiisoindole “NU-BIPHEP(O)” 3. A) Elution profiles...
Beilstein J. Org. Chem. 2016, 12, 1322–1333, doi:10.3762/bjoc.12.125
Graphical Abstract
Scheme 1: Imine formation and isomerization reactions from NH carbene complexes Cr(CO)5(E-2) (a) [27], Cr(CO)5(E/Z...
Scheme 2: Synthesis of W(CO)5(E-2) from W(CO)5(1Et) [20,21] and aminoferrocene [40,41] with concomitant formation of E-1,2-...
Scheme 3: Reaction pathways 1a/1b (migration–elimination) and 2a/2b (elimination–migration) for the formation...
Scheme 4: Reaction pathways 3a/3b/3c (CO dissociation) for the formation of imine E-3 from W(CO)5(E-2).
Figure 1: DFT calculated oxidative addition/pseudorotation/reductive elimination pathway 3c from W(CO)4(E-2) ...
Figure 2: DFT calculated geometries of the two hydrido intermediates cis(N,H)-W(CO)4(H)(Z-15) and cis(C,H)-W(...
Scheme 5: Proposed reaction sequence from W(CO)5(E-2) to W(CO)5(PPh3) in the presence of triphenylphosphane.
Beilstein J. Org. Chem. 2016, 12, 846–853, doi:10.3762/bjoc.12.83
Graphical Abstract
Figure 1: P,N-ligand frameworks studied in this work.
Scheme 1: Synthesis of N-phosphanylformamidines 2 and 3. Reaction conditions: (i) t-BuLi, THF, −78 °C to rt, ...
Scheme 2: Synthesis of phosphanylformamidines 5 and 7. Reaction conditions: (i) t-BuLi, THF, −78 °C to rt, 1 ...
Scheme 3: Synthesis of complexes [2-M(cod)]X, [3-M(cod)]X, [5-M(cod)]X and [7-M(cod)]X. M = Rh, Ir; X = BF4− ...
Figure 2: Molecular structures of [2a-Rh(cod)]+ (A), [5-Ir(cod)]+ (B), and [7-Rh(cod)]+ (C,D). Anisotropic di...
Figure 3: Coordination of ligands 2a and 5 to Rh(III) and Ir(III) precursors. Yields: [2a-Cp*RhCl]BF4 = 87%, [...
Figure 4: Molecular structures of [2a-Cp*IrI]+ (left) and [5-Cp*IrI]+ (right). Anisotropic displacement ellip...
Figure 5: Formation of palladium complexes of ligands 2a, 5 and 7. (A) Formation of [2a-PdCl2] and [2a-PdCl]2...
Figure 6: Molecular structures of [2a-PdCl2] (left) and [5-Pd(2-Me-allyl)]+ (right). Anisotropic displacement...
Beilstein J. Org. Chem. 2016, 12, 835–845, doi:10.3762/bjoc.12.82
Graphical Abstract
Figure 1: Types of aryl pyridines and pyrimidines already prepared in our group [23-27].
Scheme 1: Synthesis of diarylpyridines 4–29.
Scheme 2: Synthetic routes leading to unsymmetrically substituted arylpyridines.
Scheme 3: Preparation of unsymmetrical 3,5-diaryl-2,4,6-trimethylpyridines 46–56.
Scheme 4: Preparation of unsymmetrical 3,5-diaryl-4-chloro-2,6-dimethylpyridines 68–71.
Beilstein J. Org. Chem. 2016, 12, 769–795, doi:10.3762/bjoc.12.77
Graphical Abstract
Figure 1: Structures of the naturally occurring muraymycins isolated by McDonald et al. [22].
Figure 2: Structures of selected classes of nucleoside antibiotics. Similarities to the muraymycins are highl...
Figure 3: Structure of peptidoglycan. Long chains of glycosides (alternating GlcNAc (green) and MurNAc (blue)...
Figure 4: Schematic representation of bacterial cell wall biosynthesis.
Figure 5: Translocase I (MraY) catalyses the reaction of UDP-MurNAc-pentapeptide with undecaprenyl phosphate ...
Figure 6: Proposed mechanisms for the MraY-catalysed reaction. A: Two-step mechanism postulated by Heydanek e...
Scheme 1: First synthetic access towards simplified muraymycin analogues as reported by Yamashita et al. [76].
Scheme 2: Synthesis of (+)-caprazol (19) reported by Ichikawa, Matsuda et al. [92].
Scheme 3: Synthesis of the epicapreomycidine-containing urea dipeptide via C–H activation [96,97].
Scheme 4: Synthesis of muraymycin D2 and its epimer reported by Ichikawa, Matsuda et al. [96,97].
Scheme 5: Synthesis of the urea tripeptide unit as a building block for muraymycins reported by Kurosu et al. ...
Scheme 6: Synthesis of the uridine-derived core structure of naturally occuring muraymycins reported by Ducho...
Scheme 7: Synthesis of the epicapreomycidine-containing urea dipeptide from Garner's aldehyde reported by Duc...
Scheme 8: Synthesis of a hydroxyleucine-derived aldehyde building block reported by Ducho et al. [107].
Scheme 9: Synthesis of 5'-deoxy muraymycin C4 (65) as a closely related natural product analogue [78,109,110].
Figure 7: Summary of modifications on semisynthetic muraymycin analogues tested by Lin et al. [86]. Most active c...
Figure 8: Bioactive muraymycin analogues identified by Yamashita et al. [76].
Figure 9: Muraymycin D2 and several non-natural lipidated analogues 91a–d [77,114].
Figure 10: Non-natural muraymycin analogues with varying peptide structures [77,114].
Figure 11: SAR results for several structural variations of the muraymycin scaffold.
Figure 12: Muraymycin analogues designed for potential anti-Pseudomonas activity (most active analogues are hi...
Scheme 10: Proposed outline pathway for muraymycin biosynthesis based on the analysis of the biosynthetic gene...
Scheme 11: Biosynthesis of the nucleoside core structure of A-90289 antibiotics (which is identical to the mur...
Scheme 12: Transaldolase-catalysed formation of the key intermediate GlyU 101 in the biosynthesis of muraymyci...
Beilstein J. Org. Chem. 2016, 12, 732–744, doi:10.3762/bjoc.12.73
Graphical Abstract
Figure 1: Camphor and some camphor derivatives.
Scheme 1: Formation of 2 from reaction of oxoimine 1 with amino acids (H2NCH(R)COOH: R = H, CH3, CH2Ph, CH2CH...
Figure 2: ESI mass spectrum of 2 (positive ion mode).
Figure 3: 1H NMR spectrum of 2 in CD3CN at T = −20 °C.
Figure 4: 13C NMR spectrum of 2 in CD3CN at T = −20 °C.
Figure 5: Optimized structure of 2 ((S)-3A isomer) with labeling scheme.
Figure 6: NOESY spectrum (detail) showing the cross peak between H3A and H10A (see Supporting Information File 1, Figure S6 for the full s...
Figure 7: Upper row: anion 3 and zwitterion 4 which are stable upon geometry optimization. Middle row: zwitte...
Figure 8: Intramolecular reactions of non-zwitterionic ground state 6g to 11 (top) or 8 (bottom). The activat...
Figure 9: Transition-state geometry and salient bond distances along the IRC path for the reaction of 6g → 11...
Figure 10: Transition-state geometry and salient bond distances along the IRC path for the reaction of 6g → 8....
Figure 11: Potential products 7–11 of the Strecker degradation together with the reaction of compound 10 to gi...
Figure 12: ESI(+) tandem mass spectrum of the intermediate 12 (m/z 229) and proposed fragment ions.
Beilstein J. Org. Chem. 2016, 12, 462–495, doi:10.3762/bjoc.12.48
Graphical Abstract
Scheme 1: Activation of carbonyl compounds via enamine and iminium intermediates [2].
Scheme 2: Electronic and steric interactions present in enamine activation mode [2].
Scheme 3: Electrophilic activation of carbonyl compounds by a thiourea moiety.
Scheme 4: Asymmetric synthesis of dihydro-2H-pyran-6-carboxylate 3 using organocatalyst 4 [16].
Scheme 5: Possible hydrogen-bonding for the reaction of (E)-methyl 2-oxo-4-phenylbut-3-enoate [16].
Scheme 6: Asymmetric desymmetrization of 4,4-cyclohexadienones using the Michael addition reaction with malon...
Scheme 7: The enantioselective synthesis of α,α-disubstituted cycloalkanones using catalyst 11 [18].
Scheme 8: The enantioselective synthesis of indolo- and benzoquinolidine compounds through aza-Diels–Alder re...
Scheme 9: Enantioselective [5 + 2] cycloaddition [20].
Scheme 10: Asymmetric synthesis of oxazine derivatives 26 [21].
Scheme 11: Asymmetric synthesis of bicyclo[3.3.1]nonadienone, core 30 present in (−)-huperzine [22].
Scheme 12: Asymmetric inverse electron-demand Diels-Alder reaction catalyzed by amine-thiourea 34 [23].
Scheme 13: Asymmetric entry to morphan skeletons, catalyzed by amine-thiourea 37 [24].
Scheme 14: Asymmetric transformation of (E)-2-nitroallyl acetate [25].
Scheme 15: Proposed way of activation.
Scheme 16: Asymmetric synthesis of nitrobicyclo[3.2.1]octan-2-one derivatives [26].
Scheme 17: Asymmetric tandem Michael–Henry reaction catalyzed by 50 [27].
Scheme 18: Asymmetric Diels–Alder reactions of 3-vinylindoles 51 [29].
Scheme 19: Proposed transition state and activation mode of the asymmetric Diels–Alder reactions of 3-vinylind...
Scheme 20: Desymmetrization of meso-anhydrides by Chin, Song and co-workers [30].
Scheme 21: Desymmetrization of meso-anhydrides by Connon and co-workers [31].
Scheme 22: Asymmetric intramolecular Michael reaction [32].
Scheme 23: Asymmetric addition of malonate to 3-nitro-2H-chromenes 67 [33].
Scheme 24: Intramolecular desymmetrization through an intramolecular aza-Michael reaction [34].
Scheme 25: Enantioselective synthesis of (−)-mesembrine [34].
Scheme 26: A novel asymmetric Michael–Michael reaction [35].
Scheme 27: Asymmetric three-component reaction catalyzed by Takemoto’s catalyst 77 [46].
Scheme 28: Asymmetric domino Michael–Henry reaction [47].
Scheme 29: Asymmetric domino Michael–Henry reaction [48].
Scheme 30: Enantioselective synthesis of derivatives of 3,4-dihydro-2H-pyran 89 [49].
Scheme 31: Asymmetric addition of α,α-dicyano olefins 90 to 3-nitro-2H-chromenes 91 [50].
Scheme 32: Asymmetric three-component reaction producing 2,6-diazabicyclo[2.2.2]octanones 95 [51].
Scheme 33: Asymmetric double Michael reaction producing substituted chromans 99 [52].
Scheme 34: Enantioselective synthesis of multi-functionalized spiro oxindole dienes 106 [53].
Scheme 35: Organocatalyzed Michael aldol cyclization [54].
Scheme 36: Asymmetric synthesis of dihydrocoumarins [55].
Scheme 37: Asymmetric double Michael reaction en route to tetrasubstituted cyclohexenols [56].
Scheme 38: Asymmetric synthesis of α-trifluoromethyl-dihydropyrans 121 [58].
Scheme 39: Tyrosine-derived tertiary amino-thiourea 123 catalyzed Michael hemiaketalization reaction [59].
Scheme 40: Enantioselective entry to bicyclo[3.2.1]octane unit [60].
Scheme 41: Asymmetric synthesis of spiro[4-cyclohexanone-1,3’-oxindoline] 126 [61].
Scheme 42: Kinetic resolution of 3-nitro-2H-chromene 130 [62].
Scheme 43: Asymmetric synthesis of chromanes 136 [63].
Scheme 44: Wang’s utilization of β-unsaturated α-ketoesters 87 [64,65].
Scheme 45: Asymmetric entry to trifluoromethyl-substituted dihydropyrans 144 [66].
Scheme 46: Phenylalanine-derived thiourea-catalyzed domino Michael hemiaketalization reaction [67].
Scheme 47: Asymmetric synthesis of α-trichloromethyldihydropyrans 149 [68].
Scheme 48: Takemoto’s thiourea-catalyzed domino Michael hemiaketalization reaction [69].
Scheme 49: Asymmetric synthesis of densely substituted cyclohexanes [70].
Scheme 50: Enantioselective synthesis of polysubstituted chromeno [4,3-b]pyrrolidine derivatines 157 [71].
Scheme 51: Enantioselective synthesis of spiro-fused cyclohexanone/5-oxazolone scaffolds 162 [72].
Scheme 52: Utilizing 2-mercaptobenzaldehydes 163 in cascade processes [73,74].
Scheme 53: Proposed transition state of the initial sulfa-Michael step [74].
Scheme 54: Asymmetric thiochroman synthesis via dynamic kinetic resolution [75].
Scheme 55: Enantioselective synthesis of thiochromans [76].
Scheme 56: Enantioselective synthesis of chromans and thiochromans synthesis [77].
Scheme 57: Enantioselective sulfa-Michael aldol reaction en route to spiro compounds [78].
Scheme 58: Enantioselective synthesis of 4-aminobenzo(thio)pyrans 179 [79].
Scheme 59: Asymmetric synthesis of tetrahydroquinolines [80].
Scheme 60: Novel asymmetric Mannich–Michael sequence producing tetrahydroquinolines 186 [81].
Scheme 61: Enantioselective synthesis of biologically interesting chromanes 190 and 191 [82].
Scheme 62: Asymmetric tandem Henry–Michael reaction [83].
Scheme 63: An asymmetric synthesis of substituted cyclohexanes via a dynamic kinetic resolution [84].
Scheme 64: Three component-organocascade initiated by Knoevenagel reaction [85].
Scheme 65: Asymmetric Michael reaction catalyzed by catalysts 57 and 211 [86].
Scheme 66: Proposed mechanism for the asymmetric Michael reaction catalyzed by catalysts 57 and 211 [86].
Scheme 67: Asymmetric facile synthesis of hexasubstituted cyclohexanes [87].
Scheme 68: Dual activation catalytic mechanism [87].
Scheme 69: Asymmetric Michael–Michael/aldol reaction catalyzed by catalysts 57, 219 and 214 [88].
Scheme 70: Asymmetric synthesis of substituted cyclohexane derivatives, using catalysts 57 and 223 [89].
Scheme 71: Asymmetric synthesis of substituted piperidine derivatives, using catalysts 223 and 228 [90].
Scheme 72: Asymmetric synthesis of endo-exo spiro-dihydropyran-oxindole derivatives catalyzed by catalyst 232 [91]....
Scheme 73: Asymmetric synthesis of carbazole spiroxindole derivatives, using catalyst 236 [92].
Scheme 74: Enantioselective formal [2 + 2] cycloaddition of enal 209 with nitroalkene 210, using catalysts 23 ...
Scheme 75: Asymmetric synthesis of polycyclized hydroxylactams derivatives, using catalyst 242 [94].
Scheme 76: Asymmetric synthesis of product 243, using catalyst 246 [95].
Scheme 77: Formation of the α-stereoselective acetals 248 from the corresponding enol ether 247, using catalys...
Scheme 78: Selective glycosidation, catalyzed by Shreiner’s catalyst 23 [97].
Beilstein J. Org. Chem. 2016, 12, 377–390, doi:10.3762/bjoc.12.41
Graphical Abstract
Figure 1: Representative terpenes.
Figure 2: Two different models showing how energy evolves throughout the course of a reaction: (a) a two-dime...
Figure 3: A depiction of the “snowboarder” analogy for reactions displaying non-statistical dynamic effects. ...
Figure 4: The tetramethylbromonium ion system [14].
Figure 5: The reaction mechanisms of interest in the PES and dynamics studies of Dupuis and co-workers (R = CH...
Figure 6: The portion of the norborn-2-en-7-ylmethyl cation PES examined by Ghigo et al. [60]. Energies reported ...
Figure 7: The transformation of 2-norbornyl cation to 1,3-dimethylcyclopentyl cation.
Figure 8: Carbocation rearrangements for which trajectory calculations were used to estimate lifetimes of sec...
Figure 9: Carbocation rearrangements involved in abietadiene formation.
Figure 10: Carbocation rearrangements involved in miltiradiene formation.
Figure 11: Top: carbocation rearrangements involved in epi-isozizaene formation. Bottom: reaction coordinate d...
Beilstein J. Org. Chem. 2016, 12, 260–270, doi:10.3762/bjoc.12.28
Graphical Abstract
Scheme 1: Lewis acid-catalyzed [1,4]-H transfer/1,5-electrocyclization tandem processes of benzylidenemalonat...
Scheme 2: Preparation of benz[f]indenes 5 and 6. Reagents and conditions: i) cyclopentadiene, pyrrolidine, an...
Scheme 3: Postulated reaction path for the conversion 3a → 5a + 6a initiated by a [1,4]-hydride shift.
Scheme 4: Alternative mechanistic paths for the conversion 3a → 5a + 6a initiated by [1,5]-, [1,7]- or [1,9]-...
Scheme 5: Postulated outcome of the conversion 14 → 18 + 19 initiated by a [1,4]-deuteride shift.
Scheme 6: Preparation of deuterated benz[f]indenes 18 + 19 and 21 + 22. Reagents and conditions: i) DMSO, mic...
Scheme 7: Reagents and conditions: i) triethylamine (10%), DMSO, rt, 2 h.
Scheme 8: Preparation of benz[f]indenes 25 and 26. Reagents and conditions: i) cyclopentadiene, pyrrolidine, ...
Scheme 9: Mechanistic paths for the conversion of fulvene 3a into the benz[f]indenes 5a and 6a showing the en...
Figure 1: Optimized geometry of transition structures TS1-A, TS1-B, and TS1-C computed at the B3LYP/6-31+G** ...
Beilstein J. Org. Chem. 2016, 12, 117–124, doi:10.3762/bjoc.12.13
Graphical Abstract
Scheme 1: Equilibrium between the monoiridum complex bearing a C-bound anionic imidazolide and its correspond...
Scheme 2: Experimental routes to the “equilibrium” between 3H-H and 3H-T.
Figure 1: View of the molecular structure of a) 3H-H and b) 3H-T. Hydrogen atoms have been omitted for the sa...
Figure 2: Steric maps for the NHC ligand of 3H-H, coordinated to iridium by a) carbene or b) nitrogen. The is...
Scheme 3: Equilibrium between complexes 3–6, in the presence of CO, PMe3, and MeI.
Figure 3: View of the molecular structure of a) 4H-H and b) 4H-T (main distances in Å).
Figure 4: View of the molecular structure of 6. Hydrogen atoms have been omitted for the sake of clarity (mai...
Beilstein J. Org. Chem. 2015, 11, 2493–2508, doi:10.3762/bjoc.11.271
Graphical Abstract
Figure 1: Structures of lovastatin (1), aflatoxin B1 (2) and amphotericin B (3).
Scheme 1: a) Structure of rhizoxin (4). b) Two possible mechanisms of chain branching catalysed by a branchin...
Scheme 2: Structure of coelimycin P1 (8) and proposed biosynthetic formation from the putative PKS produced a...
Scheme 3: Structure of trioxacarcin A (9) with highlighted carbon origins of the polyketide core from acetate...
Scheme 4: Proposed biosynthetic assembly of clostrubin A (12). Bold bonds show intact acetate units.
Figure 2: Structure of forazoline A (13).
Figure 3: Structures of tyrocidine A (14) and teixobactin (15).
Figure 4: Top: Structure of the NRPS product kollosin A (16) with the sequence N-formyl-D-Leu-L-Ala-D-Leu-L-V...
Scheme 5: Proposed biosynthesis of aspirochlorine (20) via 18 and 19.
Scheme 6: Two different macrocyclization mechanisms in the biosynthesis of pyrrocidine A (24).
Figure 5: Structure of thiomarinol A (27). Bold bonds indicate carbon atoms derived from 4-hydroxybutyrate.
Figure 6: Structures of artemisinin (28), ingenol (29) and paclitaxel (30).
Figure 7: The revised (31) and the previously suggested (32) structure of hypodoratoxide and the structure of...
Figure 8: Structure of the two interconvertible conformers of (1(10)E,4E)-germacradien-6-ol (34) studied with...
Scheme 7: Proposed cyclization mechanism of corvol ethers A (42) and B (43) with the investigated reprotonati...
Scheme 8: Predicted (top) and observed (bottom) 13C-labeling pattern in cyclooctatin (45) after feeding of [U-...
Scheme 9: Proposed mechanism of the cyclooctat-9-en-7-ol (52) biosynthesis catalysed by CotB2. Annotated hydr...
Scheme 10: Cyclization mechanism of sesterfisherol (59). Bold lines indicate acetate units; black circles repr...
Scheme 11: Cyclization mechanisms to pentalenene (65) and protoillud-6-ene (67).
Scheme 12: Reactions of chorismate catalyzed by three different enzyme subfamilies. Oxygen atoms originating f...
Scheme 13: Incorporation of sulfur into tropodithietic acid (72) via cysteine.
Scheme 14: Biosynthetic proposal for the starter unit of antimycin biosynthesis. The hydrogens at positions R1...
Beilstein J. Org. Chem. 2015, 11, 2370–2387, doi:10.3762/bjoc.11.259
Graphical Abstract
Figure 1: Biocatalytic routes for conversion of CO2 into compounds with carbon in the reduced oxidation state...
Figure 2: Carbonic anhydrase-catalysed rapid interconversion of CO2 and HCO3− in living systems.
Scheme 1: The Calvin cycle for fixation of CO2 with RuBisCO.
Scheme 2: The reductive TCA cycle with CO2 fixation enzymes designated.
Scheme 3: The Wood–Ljungdahl pathway for generation of acetyl-CoA through reduction of CO2 to formate and CO....
Scheme 4: The acyl-CoA carboxylase pathways for autotrophic CO2 fixation. ACC: acetyl-CoA/propionyl-CoA carbo...
Figure 3: RuBisCO CO2-fixing bypass installed in E. coli and S. cerevisiae to increase carbon flux toward pro...
Scheme 5: Integrated biocatalytic system for carboxylation of phosphoenolpyruvate (19), using PEPC and carbon...
Scheme 6: PEPC and pyruvate carboxylase catalysed carboxylation of pyruvate backbone for the generation of ox...
Scheme 7: Decarboxylase catalysed carboxylation of (a) phenol derivatives, (b) indole and (c) pyrrole.
Figure 4: Formate dehydrogenase (FDH) catalysed reversible reduction of CO2 to formate with electron donor re...
Figure 5: Sequential generation of formate, formaldehyde and methanol from CO2 using reducing equivalents sou...
Figure 6: Hydrogen storage as formic acid through biocatalytic hydrogenation of CO2 and subsequent on-demand ...
Figure 7: Schematic showing required flow of reducing equivalents for CO2 fixation through biotechnological a...
Beilstein J. Org. Chem. 2015, 11, 1447–1457, doi:10.3762/bjoc.11.157
Graphical Abstract
Scheme 1: Synthetic route to spiroketals 2–4. Reaction conditions: a) Na2S2O5/HCOOH/EtOH/water/70 °C, b) DCl/...
Figure 1: Modelling-derived structure of 2 showing key nOe interactions (calculated distances in Å).
Figure 2: Time-dependent 1H NMR spectra of 2, 3 and 4 (13-H multiplets region). The experiments were performe...
Figure 3: Interconversion kinetics of compounds 2 (blue), 3 (orange) and 4 (grey).
Figure 4: Modelling-derived structure of 3 showing key nOe interactions (calculated distances in Å).
Figure 5: Modelling-derived structure of compound 4 showing key nOe interactions (calculated distances in Å).
Figure 6: Comparison of the spiroketal ring system stereochemistry and conformations in compounds 2–4.
Figure 7: Overlay of the computed structures of 3 (green) and 4 (blue).
Scheme 2: Postulated mechanism for the formation of compounds 2–4.
Beilstein J. Org. Chem. 2015, 11, 1441–1446, doi:10.3762/bjoc.11.156
Graphical Abstract
Scheme 1: Preparation of propargylamides through alkylation of secondary amides and base-catalyzed isomerizat...
Figure 1: Set of studied compounds.
Figure 2: Anti and syn conformations around the N–C=C=C bond for N-allenyl compounds 12b–14b.
Beilstein J. Org. Chem. 2015, 11, 481–492, doi:10.3762/bjoc.11.54
Graphical Abstract
Scheme 1: The synthesis of N-monoallylated indigo derivatives.
Scheme 2: The synthesis of 8a-hydroxyazepinodiindolones.
Figure 1: The structure and X-ray crystal structure (ball and stick representation) of azepinodiindolone 7. T...
Figure 2: Dihydroazepino[1,2-a:3,4-b']diindolones from Nb-acyl-L-tryptophanamides [5].
Scheme 3: The optimal synthesis of spiro heterocycles 12–16, and spiro/polyfused ring heterocycles 17 and 18 ...
Scheme 4: The synthesis of the oxa-bridged azepinodiindolone 22 from indigo and 1-bromo-3-methylbut-2-ene.
Figure 3: Modelled structure (Spartan 10, v1.1.0, Wavefunction Inc) of bridged indigo-tetrahydrofuran product ...
Scheme 5: The reaction of indigo with cinnamyl bromide yielding two spiro-based derivatives.
Figure 4: Structural analysis of compound 23. Left: modelled structure showing the cisoid configuration of th...
Scheme 6: Proposed mechanism for the synthesis of the red diindolone heterocycles and the azepinodiindolones.
Scheme 7: Proposed mechanism for the formation of 22. The order of protonation and allylation is undetermined....
Scheme 8: Proposed mechanism for the formation of 23 from intermediate 29.
Scheme 9: Proposed key branch points and mechanistic sinks in the base-catalysed cascade allylation reactions...
Scheme 10: Reaction of the spiro heterocycle 12 with Grubbs' II catalyst, and X-ray crystal structure of the n...
Beilstein J. Org. Chem. 2014, 10, 2963–2974, doi:10.3762/bjoc.10.314
Graphical Abstract
Scheme 1: Equilibrium between single-stranded ILPR-DNA a2 and its parallel and antiparallel quadruplex form.
Figure 1: Structures of ligands 1–6 used in this study.
Figure 2: A) CD spectra of ILPR-DNA a2 (20 μM) at different temperatures in potassium phosphate buffer (95 mM...
Figure 3: CD spectra of ILPR-sequence a2 (20 µM) in potassium phosphate buffer (95 mM, pH 7.0; __ : immediate...
Figure 4: Fluorimetric monitoring of thermal DNA-denaturation of the ILPR quadruplex Fa2T (0.2 μM DNA concent...
Figure 5: Fluorimetric titration of 1a (A), 1b (B), 1c (C), 1d (D) and 1e (E) with a2 in potassium phosphate ...
Figure 6: Fluorimetric titration of 2 (A), 3 (B), 4 (C), 5 (D) and 6 (E) with a2 in potassium phosphate buffe...
Figure 7: Job plot from fluorimetric analysis of mixtures of ligands 1e (A), 4 (B) and 6 (C) with ILPR-DNA a2...
Figure 8: CD spectra of ILPR-DNA a2 in the presence of 1d (A), 1e (B), 2 (C), 4 (D), 5 (E) and 6 (F) at LDR =...
Beilstein J. Org. Chem. 2014, 10, 2521–2530, doi:10.3762/bjoc.10.263
Graphical Abstract
Scheme 1: The sterically congested model systems.
Scheme 2: Preparation and derivatives of the α-arylvinyllithium 4, where Don = ½TMEDA and d = 2 for the purif...
Figure 1: 13C and (in parentheses) 1H NMR lithiation shifts Δδ = δ(R–Li) − δ(R–H) [ppm] of the monomers (“M”) ...
Scheme 3: THF-catalyzed ionization of ground-state 11 (CIP) generates the solvent-separated ion pair 12 (SSIP...
Figure 2: Arrhenius diagram of the natural logarithms of pseudo-first-order rate constants kψ [s−1] of sp2-st...
Beilstein J. Org. Chem. 2014, 10, 1967–1980, doi:10.3762/bjoc.10.205
Graphical Abstract
Figure 1: Examples of biologically active acyclic and cyclic nucleotide analogs.
Figure 2: The pyrrolidine nucleotide analogs investigated in this study.
Scheme 1: The synthesis of pyrrolidine nucleotides 7–14.
Figure 3: The numbering of the pyrrolidine ring, the nucleobase and the endocyclic phase angles for the purpo...
Figure 4: The aliphatic part (pyrrolidine protons) of the 1H NMR spectra of 9 measured in D2O at different pD...
Figure 5: Changes of selected 1H and 13C chemical shifts of 9 upon pD change.
Figure 6: The deuteration equilibria of phosphonomethyl derivatives 7–10.
Figure 7: The aliphatic part (pyrrolidine protons) of the 1H NMR spectra of 13 measured in D2O at different p...
Figure 8: Amide rotamers of phosphonoformyl derivatives 11–14.
Figure 9: The 31P NMR spectra (202.3 MHz) of 14 measured (the black curve) and simulated (the red curve) at v...
Figure 10: A part of the H,C-HSQC spectrum of derivative 13, showing the assignment of rotamers A and B.
Figure 11: The pseudorotation pathway of the pyrrolidine ring in the compounds studied. The sign B stands for ...
Figure 12: An example of the stereospecific assignment of pyrrolidine-ring protons of 14 in the H,H-ROESY spec...
Figure 13: The energy profile of the five-membered pyrrolidine ring pseudorotation for adenine derivatives 9 a...
Figure 14: The most stable conformations of adenine derivatives 9 and 13A calculated by the B3LYP/6-31++G* met...
Beilstein J. Org. Chem. 2014, 10, 752–760, doi:10.3762/bjoc.10.70
Graphical Abstract
Scheme 1: Preparation of enol ethers.
Scheme 2: Reaction of enol ethers with hydrazine hydrate.
Scheme 3: Pyrazoles 5.
Figure 1: Tautomers of 5a.
Figure 2: Tautomers of 5b (R = Me), 5c (R = Et).
Figure 3: Tautomers of 5b (R = Me), 5c (R = Et).
Figure 4: Tautomers of 5d.
Scheme 4: Reactions of hydrazine hydrate with dialkyl alkoxymethylidenemalonates.
Figure 5: Crystal structure and crystal packing of compound 6a.
Figure 6: Key 1H (red), 13C (black) and 15N (blue) NMR chemical shifts (δ, ppm) in isomers A and B of compoun...
Figure 7: DFT optimized isomers of compound 6a. (Distances are in Å, angles are in degrees.)